Purified islets for transplant
Purified islets for transplant

Our Research Advances Care

Part of a world-renowned academic medical center, the Massachusetts General Hospital Transplant Center is an innovator in improving the lives of transplant patients in New England and worldwide.

From thebreakthrough transplant procedurein tolerance induction to avoid lifelong dependence on immunosuppressive drugs, to tissue engineering, to studies of xenotransplantation, to new protocols that reduce wait times and shorten hospital stays for lung transplant patients, our research discoveries continue to revolutionize transplant medicine around the globe.

Our research focuses on:

  • Reducing or preventing organ rejection
  • Eliminating infectious disease in transplantation
  • Addressing organ incompatibility
  • Enabling patients to live drug free after transplantation
  • Creating new tissues using a patient’s own cells

Advanced Treatments Through Clinical Trials

We offer some of the most innovative clinical trials in the country. This clinical research helps move important laboratory discoveries to the patient’s bedside and gives patients the opportunity to partner with their physicians to advance care. Some of our recent discoveries have already been put into practice to improve the success rates of kidney transplants.

What Will We Discover Next?


We are evaluating how a variety of new drugs, medical devices and therapies may increase survival rates and provide alternatives for heart disease patients who are not transplant candidates. We are also investigating whether gene therapy may help reverse heart failure. Our work includes novel approaches to heart care, including noninvasive diagnostic tools and earlier interventions.

Learn about the
Heart Transplant Program


Our groundbreaking work in tolerance induction means that some patients can now avoid taking lifelong immunosuppressive drugs after kidney transplantation. We continue to investigate new approaches to improve transplant success rates, including a new procedure for kidney transplantation between persons with incompatible blood types. We are also working to increase the pool of available donors and enhance quality of life post-transplant.

Learn about the
Kidney Transplant Program


The Transplant Center offers highly advanced treatments through clinical trials. Current trials involve using a liver assist device in bridge therapy and novel immunosuppressive drugs to decrease hepatitis C reinfection rates after transplantation. In addition to pioneering new treatments for patients with liver failure, we are also working to improve the success of liver transplants through therapies that treat organ rejection.

Learn about the
Liver Transplant Program


Our work in this area explores both lung transplantation and the diseases that cause the need for transplants. Developing treatments include stem cell transplantation to better understand how airways heal and improve transplant results. We are also part of a multicenter trial into a new drug to treat pulmonary fibrosis.

Learn about the
Lung Transplant Program


The Transplant Center is one of the few centers in the world to investigate islet cell transplantation, a less invasive alternative to pancreas transplants for patients with type 1 diabetes. Upcoming clinical trials will focus on helping these patients become insulin independent.

Learn about the
Pancreas/Islet Program

Organ Preservation

Innovative studies are underway to improve the preservation and function of organs from deceased donors. In the future, ongoing laboratory studies may help solve the organ shortage by uncovering alternative sources for organs.

Back to Top